NCT02973711 2021-02-16
A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML
University of Michigan Rogel Cancer Center
Phase 1/2 Withdrawn
Clinical Trials
5 trialsNCT02421926 2019-07-08
IDEAL-E
Asan Medical Center
Withdrawn
NCT02774512 2017-10-06
ZAK-0
Institut Bergonié
Phase EARLY_PHASE1 Withdrawn
NCT01605981 2017-04-20
MACS1881
Novartis
Phase 4 Withdrawn
NCT01270893 2012-08-02
Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST)
M.D. Anderson Cancer Center
Phase 2 Withdrawn